24 Caught for Human Ova Trading
By The Korea Times,
The Korea Times
| 11. 14. 2005
Police have caught 20 women and four brokers on charges of trading in human ova.
Trading in human ova is banned under the bioethics law.
Police Monday said that they requested an arrest warrant for a 44-year-old broker, identified as Yoo, for pocketing about 6.5 billion won from 395 women since in 2003.
Yoo allegedly connected infertile Japanese women to Korean women for ova transactions via online Web sites both in Korea and Japan.
Police also booked three other brokers who worked with Yoo and 20 Korean women for selling and buying the eggs.
According to police, 11 women allegedly sold their eggs and nine women purchased them for 2.5 million won since the bioethics law went into effect in January.
Those who violate the law are subject to prison terms of up to three years according to the bioethics law, which bans any trade of ovum or sperm for money.
The law allows women to donate their ova to infertile couples or for scientific purposes but not sell or buy them.
A college student is believed to have provided...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...